| Cas No.: | 211915-06-9 |
| 名称: | (E)-ethyl 3-(2-((4-(N'-(hexyloxycarbonyl)carbamimidoyl)phenylamino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |
| 别名: | BIBR 1048, Dabigatran etexilate,BIBR1048 |
| SMILES: | CCCCCCOC(=O)/N=C(/C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4)\N |
| 分子式: | C34H41N7O5 |
| 分子量: | 627.73 |
| 纯度: | |
| 保存条件: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | |
| In Vivo: | |
| In Vitro: | |
| References: | For the detailed information about the solubility of BIBR-1048 (Dabigatran etexilate) in water, the solubility of BIBR-1048 (Dabigatran etexilate) in DMSO, the solubility of BIBR-1048 (Dabigatran etexilate) in PBS buffer, the animal experiment（test） of BIBR-1048 (Dabigatran etexilate),the in vivo,in vitro and clinical trial test of BIBR-1048 (Dabigatran etexilate),the cell experiment（test） of BIBR-1048 (Dabigatran etexilate),the IC50, EC50 and Affinity of BIBR-1048 (Dabigatran etexilate), please contact DC Chemicals. |
| Kinase Assay: | |
| Cell Assay: | |
| Animal Administration: | |
| References: |
MSDS
COA
| LOT NO. | DOWNLOAD |
|
|
|
| 2018-0101 |
|
